BioticaBio Intelligence

Medical device regulatory services

A clearer path to your 510(k) submission.

We help emerging device companies identify potential predicates, establish evidence requirements and assemble submission documentation while their engineering teams focus on development.

Discuss your technology →

Predicate assessment

Review intended use, technological characteristics and relevant FDA-cleared devices.

Evidence strategy

Map substantial equivalence questions, testing gaps and potential Pre-Submission topics.

Submission execution

Coordinate documentation, eSTAR assembly and responses to FDA requests, within an agreed scope.

Getting started

Start with a focused assessment.

Share your technology and development objectives. We will define a practical initial scope and deliverables before beginning work.

Contact BioticaBio →

Illustrative regulatory assessment

From FDA precedent to evidence strategy.

Independent example, not a client engagement or a determination of substantial equivalence.

Dental regeneration · K251062

Geistlich Bio-Gide

Class II resorbable collagen barrier membrane for guided bone and tissue regeneration. FDA product code NPL.

FDA 510(k) summary →

Evidence strategy

Novel synthetic barrier membrane

Assess intended use, barrier performance, degradation, biocompatibility and mechanical properties against relevant cleared devices. A synthetic material may require a different predicate or regulatory strategy; the collagen device is a screening precedent only.